MedTech Terms
    The authoritative reference
    All terms

    Early Feasibility Study

    FDA program enabling early human evaluation of novel devices with limited preclinical data and iterative design.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    EFSs allow first-in-human use of a novel device based on less nonclinical evidence than a traditional IDE, with allowances for iterative device modifications during the study.
    What the regulation says
    The FDA provides specific guidance on Early Feasibility Studies, outlining criteria for device selection, non-clinical data requirements, and the iterative nature of device modifications. This approach is intended to accelerate the development of novel medical devices by allowing earlier human experience (FDA, "Guidance for Industry and FDA Staff: Early Feasibility Studies for Medical Devices").

    What this means in practice

    Strategically valuable for breakthrough cardiovascular, neuro, and surgical devices needing early clinical signal to inform design freeze.

    Examples

    • A MedTech company is developing a novel neurostimulation device for refractory epilepsy and conducts an EFS to assess its initial safety and thermodynamic stability in a small cohort of patients.
    • An EFS is initiated for a new cardiovascular stent design to evaluate acute deployment success and early patency rates, allowing real-time adjustments to the delivery system.
    • A surgical robotics firm performs an EFS to test a new haptic feedback system in real surgical scenarios, making minor software adjustments based on surgeon input.
    Common pitfalls
    • •A common pitfall is misunderstanding the reduced non-clinical evidence requirements, which are still substantial and must justify the proposed human use.
    • •Another mistake is failing to adequately plan for iterative device modifications, leading to delays in regulatory approvals.
    • •Companies often underestimate the importance of strong clinical protocol design and robust data collection in EFSs.
    • •Inadequate consideration of patient safety measures during the iterative design process can lead to serious compliance issues.

    Frequently asked questions

    The primary goal is to gather initial clinical experience with a novel medical device, often a first-in-human use, to inform device design and development. It aims to evaluate the device's safety and basic functionality in a limited patient population.
    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    FDA·2ISO·1
    1. 1
      FDA EFS Guidance
      Verified
      FDAfda.gov
    2. 2
      ISO 14155 Standard Page
      Verified
      ISOiso.org
    3. 3
      FDA - Clinical Trials and Human Subject Protection
      Verified
      FDAfda.gov

    Inline markers like [1] jump to the matching reference above.